Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic.
Adult
Blood Glucose
/ analysis
COVID-19
Clinical Decision-Making
Coronavirus Infections
/ epidemiology
Diabetes, Gestational
/ diagnosis
Female
Gestational Age
Glucose Tolerance Test
/ methods
Humans
Infection Control
/ methods
Pandemics
/ prevention & control
Patient Isolation
/ methods
Pneumonia, Viral
/ epidemiology
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Pregnancy Outcome
Prenatal Diagnosis
/ methods
Risk Assessment
diagnosis
gestational diabetes mellitus
macrosomia
screening
stillbirth
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
27
04
2020
revised:
22
06
2020
accepted:
29
06
2020
pubmed:
12
8
2020
medline:
4
11
2020
entrez:
12
8
2020
Statut:
ppublish
Résumé
The balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24-28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a one-hour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L: misses 44-54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7-5.0 mmol/L (62-72% sensitive)). Choices should emphasise local and patient decision-making.
Identifiants
pubmed: 32779188
doi: 10.1111/ajo.13224
pmc: PMC7436309
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
660-666Informations de copyright
© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
N Engl J Med. 2005 Jun 16;352(24):2477-86
pubmed: 15951574
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
BJOG. 2019 Jul;126(8):973-982
pubmed: 30891907
Diabetes Care. 2011 Oct;34(10):2217-9
pubmed: 21844290
Aust N Z J Obstet Gynaecol. 2020 Oct;60(5):720-728
pubmed: 32157686
Curr Diab Rep. 2017 Oct 2;17(11):115
pubmed: 28971305
Am J Obstet Gynecol. 1994 Sep;171(3):607-16
pubmed: 8092205
Clin Chem Lab Med. 2019 Sep 25;57(10):1435-1449
pubmed: 30893053
Diabetes Care. 2012 Mar;35(3):574-80
pubmed: 22301123
Diabetes Care. 2012 Mar;35(3):526-8
pubmed: 22355019
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Int J Gynaecol Obstet. 2020 Jun;149(3):273-286
pubmed: 32248521
Diabetes Care. 2018 Oct;41(10):2053-2058
pubmed: 30237233
Diabetologia. 2016 Mar;59(3):445-52
pubmed: 26589686
Lancet Infect Dis. 2020 Jun;20(6):630-631
pubmed: 32240633
Diabetes Care. 2007 May;30(5):1314-9
pubmed: 17290037
N Engl J Med. 2009 Oct 1;361(14):1339-48
pubmed: 19797280
J Intern Med. 2014 Aug;276(2):171-3
pubmed: 24443985
Med J Aust. 2018 Nov 5;209(9):405-406
pubmed: 29793404
World J Diabetes. 2016 Jul 25;7(14):279-89
pubmed: 27525055
Diabetes Res Clin Pract. 2020 Jan;159:107953
pubmed: 31794807
Aust N Z J Obstet Gynaecol. 2020 Jun;60(3):486-488
pubmed: 32506460